The company announced in July that a biweekly, 48 mg dose of GZR18 led to an average weight loss of 17.29% after 30 weeks. Related Kailera launches with $400M series A and clutch of Chinese ...

While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...

The SA Health Products Regulatory Authority has expressed concern at the increasing presence of counterfeit products such as ...

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

Don't buy the Ozempic or Mounjaro you see online, warns SAHPRA, because you may be wasting your money or risking your health.

These pose a health risk to the public. Sahpra cautions the public to not purchase and/or consume such products as their ...

“We do not condone these practices and it’s important to understand that for Ozempic, only the marked doses on the pens (0.25 ...

SAHPRA cautions the public to not purchase and/or consume such products as their safety, efficacy, and quality have not been ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

Ozempic is actually one brand name for a drug called semaglutide, and it’s FDA-approved to help manage insulin levels in patients with type 2 diabetes. A separate version of medication, called Wegovy, ...